TNF and Parkinson disease: The current study was designed: 1) to measure the levels of serum interleukin (IL)-6, IL-8, tumor necrosis factor-α (TNF-α) in PD patients and HCs and 2) to test whether these inflammatory indicators would correlate with disease characteristics.